How many genes underlie the occurrence of common complex diseases in the population?

International Journal of Epidemiology

Volumn 34, Issue 5, 2005, Pages 1129-1137

  Yang, Quanhe ^a   Khoury, Muin J ^a   Friedman, J M ^b   Little, Julian ^c   Flanders, Dana W ^d  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d EMORY UNIVERSITY   (United States)

Author keywords

Aetiology; Epidemiology; Genes; Population attributable fraction

Indexed keywords

EPIDEMIOLOGICAL PHENOMENA;

ARTICLE; DISEASE MODEL; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; MATHEMATICAL COMPUTING; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

ALGORITHMS; ALLELES; COLORECTAL NEOPLASMS; ENVIRONMENTAL EXPOSURE; GENE FREQUENCY; GENES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MODELS, GENETIC; ODDS RATIO; PHENOTYPE; PREVALENCE; RISK FACTORS; VARIATION (GENETICS);

EID: 27544432314     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyi130     Document Type: Article

References (34)

1. Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research. Nature 2003;422:835-47.
2. Glazier AM, Nadeau JH, Aitman TJ. Finding genes that underlie complex traits. Science 2002;298:2345-49.
3. Guttmacher AE, Collins FS. Genomic medicine - a primer. N Engl J Med 2002;347:1512-20.
4. Wang WY, Barratt BJ, Clayton DG, Todd JA. Genome-wide association studies: Theoretical and practical concerns. Nat Rev Genet 2005;6:109-18.
5. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005;6:95-108.
6. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001;17:502-10.
7. Merikangas KR, Risch N. Genomic priorities and public health. Science 2003;302:599-601.
8. Khoury MJ, Yang Q, Gwinn M, Little J, Dana Flanders W. An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genet Med 2004;6:38-47.
9. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia: Lippincott-Raven, 1998.
10. Kleinbaum DG, Morgenstern H, Kupper LL. Epidemiologic research: principles and quantitative methods. Belmont, CA: Lifetime Learning Publications, 1982.
11. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002;4:45-61.
12. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-82.
13. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001; 29:306-9.
14. Janssens AC, Pardo MC, Steyerberg EW, van Duijn CM. Revisiting the clinical validity of multiplex genetic testing in complex diseases. Am J Hum Genet 2004;74:585-88.
15. Ries LAG, Eisner MP, Kosary CL et al. SEER Cancer Statistics Review, 1975-2001. National Cancer Institute. Bethesda, MD: National Cancer Institute, 2004. Available at: http://seer.cancer.gov/csr/1975_2001/
16. de Jong MM, Nolte IM, te Meerman GJ et al. Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2002;11:1332-52.
17. Northridge ME. Public health methods - attributable risk as a link between causality and public health action. Am J Public Health 1995;85:1202-4.
18. Little J, Bradley L, Bray MS et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002;156:300-10.
19. Terwilliger JD, Weiss KM. Confounding, ascertainment bias, and the blind quest for a genetic 'fountain of youth'. Ann Med 2003; 35:532-44.
20. Hannon HW, Henderson OL, Bell CJ. Newborn Screening Quality Assurance. In: Khoury MJ, Burke W, Thomson EJ (eds). Genetics and public health in the 21st century: Using genetic information to improve health and prevent disease. Oxford; New York: Oxford University Press, 2000, p. 639.
21. Davey Smith G, Ebrahim S. 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
22. Little J, Khoury MJ. Mendelian randomisation: A new spin or real progress? Lancet 2003;362:930-31.
23. Davey Smith G, Ebrahim S. Mendelian randomization: Prospects, potentials, and limitations. Int J Epidemiol 2004;33:30-42.
24. Vineis P, Schulte P, McMichael AJ. Misconceptions about the use of genetic tests in populations. Lancet 2001;357:709-12.
25. Wacholder S. The impact of a prevention effort on the community. Epidemiology 2005;16:1-3.
26. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001;69:124-37.
27. Wright AF, Hastie ND. Complex genetic diseases: Controversy over the Croesus code. Genome Biol 2001;2:COMMENT2007.
28. Becker KG. The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 2004; 62:309-17.
29. Willett WC. Balancing life-style and genomics research for disease prevention. Science 2002;296:695-98.
30. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001;358:1356-60.
31. Nallamothu BK, Fendrick AM, Rubenfire M, Saint S, Bandekar RR, Omenn GS. Potential clinical and economic effects of homocyst(e)ine lowering. Arch Intern Med 2000;160:3406-12.
32. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. Monographs in Epidemiology and Biostatistics v. 22. New York: Oxford University Press, 1993. Vol. vi, p. 383.
33. Hartl DL, Clark AG. Principles of population genetics. Sunderland, MA: Sinauer Associates, 1997. Vol. xiii, p. 542.
34. Risch N. The genetic epidemiology of cancer: Interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2001;10:733-41.